Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

Clinical trial NCT05191004 · WITHDRAWN

Trial details

NCT number: NCT05191004
Sponsor: Nuvation Bio Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Metastatic Breast Cancer Breast Cancer Breast Carcinoma Cancer of the Breast Cancer of Breast Malignant Tumor of Breast Breast Tumor

Start date: 2022-09-01
Primary completion: 2025-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.